Julius Knowles

Insider Reports History

Location
Somerville, MA
Signature
/s/ Keith Regnante, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Julius Knowles:

Company Role Class Num Shares Value Price $ Report Date Ownership
Keros Therapeutics, Inc. Director Common Stock 102,233 $1,814,635 $17.75 21 Nov 2025 Indirect
Keros Therapeutics, Inc. Director Common Stock 6,441 $112,717 $17.50 21 Nov 2025 Direct
Keros Therapeutics, Inc. Director Stock Option (right to buy) 10,500 04 Jun 2025 Direct

Insider Reports Filed by Julius Knowles

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KROS Keros Therapeutics, Inc. 21 Nov 2025 2 -$5,715,873 4 Director 18 Dec 2025, 16:15
KROS Keros Therapeutics, Inc. 04 Jun 2025 2 $0 4 Director 06 Jun 2025, 16:15
KROS Keros Therapeutics, Inc. 30 May 2024 1 $0 4 Director 03 Jun 2024, 16:15
KROS Keros Therapeutics, Inc. 06 Jun 2023 1 $0 4 Director 08 Jun 2023, 16:42
KROS Keros Therapeutics, Inc. 01 Jun 2022 1 $0 4 Director 03 Jun 2022, 16:28
KROS Keros Therapeutics, Inc. 03 Jan 2022 24 -$2,756,116 4 Director 05 Jan 2022, 18:14
KROS Keros Therapeutics, Inc. 01 Dec 2021 16 -$2,577,376 4 Director 03 Dec 2021, 16:05
KROS Keros Therapeutics, Inc. 01 Nov 2021 12 -$2,007,129 4 Director 03 Nov 2021, 19:04
KROS Keros Therapeutics, Inc. 19 Oct 2021 8 -$328,441 4 Director 21 Oct 2021, 16:29
KROS Keros Therapeutics, Inc. 14 Oct 2021 12 -$1,016,653 4 Director 18 Oct 2021, 20:35
KROS Keros Therapeutics, Inc. 01 Oct 2021 6 -$508,755 4 Director 05 Oct 2021, 20:47
KROS Keros Therapeutics, Inc. 27 Sep 2021 6 -$3,924,003 4 Director 29 Sep 2021, 16:39
KROS Keros Therapeutics, Inc. 01 Jul 2021 10 -$1,968,352 4 Director 06 Jul 2021, 18:02
KROS Keros Therapeutics, Inc. 04 Jun 2021 16 -$952,613 4 Director 08 Jun 2021, 16:31
KROS Keros Therapeutics, Inc. 01 Jun 2021 20 -$1,403,553 4 Director 03 Jun 2021, 20:06
KROS Keros Therapeutics, Inc. 01 Jun 2021 1 $0 4 Director 03 Jun 2021, 17:33
KROS Keros Therapeutics, Inc. 13 Apr 2020 1 +$24,987 4 Director 20 Jan 2023, 15:32